Therapeutics: Src homology protein tyrosine phosphatase 2 (SHP-2; SHPTP2; PTPN11); receptor tyrosine kinase (RTK)

Cancer

INDICATION: Cancer; leukemia

In vitro, cell culture and mouse studies identified a SHP-2 inhibitor that

Read the full 141 word article

How to gain access

Continue reading with a
two-week free trial.